NCT03833700 2026-02-27A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)Eisai Inc.Phase 1 Active not recruiting70 enrolled
NCT07406633 2026-02-12KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line SettingKumquat Biosciences Inc.Phase 2 Not yet recruiting46 enrolled
NCT03093116 2025-07-10TRIDENT-1Turning Point Therapeutics, Inc.Phase 1/2 Recruiting500 enrolled 2 FDA
NCT05160168 2024-06-05A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)Theseus PharmaceuticalsPhase 1/2 Terminated32 enrolled 20 charts
NCT01275222 2021-06-25Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal TumorsNovartisPhase 1/2 Completed117 enrolled 18 charts
NCT00867113 2018-03-14Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)NovartisPhase 2 Completed91 enrolled 11 charts